Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Emerson Bernardes; Peter Caravan; R. Michael van Dam; Winnie Deuther-Conrad; Beverley Ellis; Shozo Furumoto; Benjamin Guillet; Ya Yao Huang; Hongmei Jia; Peter Laverman; Zijing Li; Zhaofei Liu; Filippo Lodi; Yubin Miao; Lars Perk; Ralf Schirrmacher; Johnny Vercoullie; Hua Yang; Min Yang; Xing Yang; Junbo Zhang; Ming Rong Zhang; Hua Zhu

doi:10.1186/s41181-022-00162-3

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Emerson Bernardes, Peter Caravan, R. Michael van Dam, Winnie Deuther-Conrad, Beverley Ellis, Shozo Furumoto, Benjamin Guillet, Ya Yao Huang, Hongmei Jia, Peter Laverman, Zijing Li, Zhaofei Liu, Filippo Lodi, Yubin Miao, Lars Perk, Ralf Schirrmacher, Johnny Vercoullie, Hua Yang, Min Yang, Xing YangJunbo Zhang, Ming Rong Zhang, Hua Zhu

Cyclotron and Radioisotope Center (CYRIC)

Research output: Contribution to journal › Review article › peer-review

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Conclusion: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Original language	English
Article number	9
Journal	EJNMMI Radiopharmacy and Chemistry
Volume	7
Issue number	1
DOIs	https://doi.org/10.1186/s41181-022-00162-3
Publication status	Published - 2022 Dec

Keywords

Highlights
Radiochemistry
Radiopharmacy
Review

ASJC Scopus subject areas

Analytical Chemistry
Radiology Nuclear Medicine and imaging
Pharmacology
Pharmacology (medical)

Access to Document

10.1186/s41181-022-00162-3

Cite this

Bernardes, E., Caravan, P., van Dam, R. M., Deuther-Conrad, W., Ellis, B., Furumoto, S., Guillet, B., Huang, Y. Y., Jia, H., Laverman, P., Li, Z., Liu, Z., Lodi, F., Miao, Y., Perk, L., Schirrmacher, R., Vercoullie, J., Yang, H., Yang, M., ... Zhu, H. (2022). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI Radiopharmacy and Chemistry, 7(1), [9]. https://doi.org/10.1186/s41181-022-00162-3

Bernardes, E, Caravan, P, van Dam, RM, Deuther-Conrad, W, Ellis, B, Furumoto, S, Guillet, B, Huang, YY, Jia, H, Laverman, P, Li, Z, Liu, Z, Lodi, F, Miao, Y, Perk, L, Schirrmacher, R, Vercoullie, J, Yang, H, Yang, M, Yang, X, Zhang, J, Zhang, MR & Zhu, H 2022, 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board', EJNMMI Radiopharmacy and Chemistry, vol. 7, no. 1, 9. https://doi.org/10.1186/s41181-022-00162-3

@article{2091b301f02f4f2ea77873e0e214b1da,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board",

abstract = "Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Conclusion: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.",

keywords = "Highlights, Radiochemistry, Radiopharmacy, Review",

author = "Emerson Bernardes and Peter Caravan and {van Dam}, {R. Michael} and Winnie Deuther-Conrad and Beverley Ellis and Shozo Furumoto and Benjamin Guillet and Huang, {Ya Yao} and Hongmei Jia and Peter Laverman and Zijing Li and Zhaofei Liu and Filippo Lodi and Yubin Miao and Lars Perk and Ralf Schirrmacher and Johnny Vercoullie and Hua Yang and Min Yang and Xing Yang and Junbo Zhang and Zhang, {Ming Rong} and Hua Zhu",

note = "Funding Information: Open Access funding enabled and organized by Projekt DEAL. Financial support from EJNMMI Radiopharmacy and Chemistry to make this review article available for Open Access is gratefully acknowledged. Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = dec,

doi = "10.1186/s41181-022-00162-3",

language = "English",

volume = "7",

journal = "EJNMMI Radiopharmacy and Chemistry",

issn = "2365-421X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board

AU - Bernardes, Emerson

AU - Caravan, Peter

AU - van Dam, R. Michael

AU - Deuther-Conrad, Winnie

AU - Ellis, Beverley

AU - Furumoto, Shozo

AU - Guillet, Benjamin

AU - Huang, Ya Yao

AU - Jia, Hongmei

AU - Laverman, Peter

AU - Li, Zijing

AU - Liu, Zhaofei

AU - Lodi, Filippo

AU - Miao, Yubin

AU - Perk, Lars

AU - Schirrmacher, Ralf

AU - Vercoullie, Johnny

AU - Yang, Hua

AU - Yang, Min

AU - Yang, Xing

AU - Zhang, Junbo

AU - Zhang, Ming Rong

AU - Zhu, Hua

N1 - Funding Information: Open Access funding enabled and organized by Projekt DEAL. Financial support from EJNMMI Radiopharmacy and Chemistry to make this review article available for Open Access is gratefully acknowledged. Publisher Copyright: © 2022, The Author(s).

PY - 2022/12

Y1 - 2022/12

N2 - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Conclusion: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

AB - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Conclusion: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

KW - Highlights

KW - Radiochemistry

KW - Radiopharmacy

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=85128828578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128828578&partnerID=8YFLogxK

U2 - 10.1186/s41181-022-00162-3

DO - 10.1186/s41181-022-00162-3

M3 - Review article

AN - SCOPUS:85128828578

SN - 2365-421X

VL - 7

JO - EJNMMI Radiopharmacy and Chemistry

JF - EJNMMI Radiopharmacy and Chemistry

IS - 1

M1 - 9

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this